- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial2019 | Publication without faculty affiliation
- Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)2016 | Publication without faculty affiliation
- Nintedanib in the treatment of idiopathic pulmonary fibrosis2016 | First Faculty of Medicine
- Angiogenic markers in canine lymphoma tissues do not predict survival times in chemotherapy treated dogs2012 | Faculty of Medicine in Pilsen
- Disturbed angiogenesis in intrauterine growth restriction-compromised placentas at term2018 | First Faculty of Medicine, Faculty of Science
- The Effects of Prenatal Pravastatin Treatment in the Rabbit Fetal Growth Restriction Model2023 | Third Faculty of Medicine
- Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study2018 | Publication without faculty affiliation
- Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation2015 | First Faculty of Medicine
- Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors2022 | Faculty of Pharmacy in Hradec Králové
- Dysfunctional Microvasculature as a Consequence of Shb Gene Inactivation Causes Impaired Tumor Growth2009 | Second Faculty of Medicine
